Global Pneumococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

According to our (Global Info Research) latest study, the global Pneumococcal Vaccine market size was valued at USD 7408.6 million in 2022 and is forecast to a readjusted size of USD 7972.1 million by 2029 with a CAGR of 1.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

This report is a detailed and comprehensive analysis for global Pneumococcal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Pneumococcal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Pneumococcal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Pneumococcal Vaccine market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Pneumococcal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pneumococcal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pneumococcal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, MSD, Sanofipasteur and CDIBP. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Pneumococcal Vaccine market is split by Type and by End User. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    PPSV 23
    PCV 7/13
    PCV 10

Market segment by End User
    Child
    Adult

Major players covered
    Pfizer
    GSK
    MSD
    Sanofipasteur
    CDIBP

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine from 2018 to 2023.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and end user, with sales market share and growth rate by type, end user, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pneumococcal Vaccine market forecast, by regions, type and end user, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine.
Chapter 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pneumococcal Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Pneumococcal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 PPSV 23
        1.3.3 PCV 7/13
        1.3.4 PCV 10
    1.4 Market Analysis by End User
        1.4.1 Overview: Global Pneumococcal Vaccine Consumption Value by End User: 2018 Versus 2022 Versus 2029
        1.4.2 Child
        1.4.3 Adult
    1.5 Global Pneumococcal Vaccine Market Size & Forecast
        1.5.1 Global Pneumococcal Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Pneumococcal Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Pneumococcal Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Pneumococcal Vaccine Product and Services
        2.1.4 Pfizer Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Pneumococcal Vaccine Product and Services
        2.2.4 GSK Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GSK Recent Developments/Updates
    2.3 MSD
        2.3.1 MSD Details
        2.3.2 MSD Major Business
        2.3.3 MSD Pneumococcal Vaccine Product and Services
        2.3.4 MSD Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 MSD Recent Developments/Updates
    2.4 Sanofipasteur
        2.4.1 Sanofipasteur Details
        2.4.2 Sanofipasteur Major Business
        2.4.3 Sanofipasteur Pneumococcal Vaccine Product and Services
        2.4.4 Sanofipasteur Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sanofipasteur Recent Developments/Updates
    2.5 CDIBP
        2.5.1 CDIBP Details
        2.5.2 CDIBP Major Business
        2.5.3 CDIBP Pneumococcal Vaccine Product and Services
        2.5.4 CDIBP Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 CDIBP Recent Developments/Updates

3 Competitive Environment: Pneumococcal Vaccine by Manufacturer
    3.1 Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Pneumococcal Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Pneumococcal Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2022
    3.5 Pneumococcal Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Pneumococcal Vaccine Market: Region Footprint
        3.5.2 Pneumococcal Vaccine Market: Company Product Type Footprint
        3.5.3 Pneumococcal Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Pneumococcal Vaccine Market Size by Region
        4.1.1 Global Pneumococcal Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Pneumococcal Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Pneumococcal Vaccine Average Price by Region (2018-2029)
    4.2 North America Pneumococcal Vaccine Consumption Value (2018-2029)
    4.3 Europe Pneumococcal Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Pneumococcal Vaccine Consumption Value (2018-2029)
    4.5 South America Pneumococcal Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Pneumococcal Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Pneumococcal Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Pneumococcal Vaccine Average Price by Type (2018-2029)

6 Market Segment by End User
    6.1 Global Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    6.2 Global Pneumococcal Vaccine Consumption Value by End User (2018-2029)
    6.3 Global Pneumococcal Vaccine Average Price by End User (2018-2029)

7 North America
    7.1 North America Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    7.3 North America Pneumococcal Vaccine Market Size by Country
        7.3.1 North America Pneumococcal Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Pneumococcal Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    8.3 Europe Pneumococcal Vaccine Market Size by Country
        8.3.1 Europe Pneumococcal Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Pneumococcal Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    9.3 Asia-Pacific Pneumococcal Vaccine Market Size by Region
        9.3.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    10.3 South America Pneumococcal Vaccine Market Size by Country
        10.3.1 South America Pneumococcal Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Pneumococcal Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2018-2029)
    11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Country
        11.3.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Pneumococcal Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Pneumococcal Vaccine Market Drivers
    12.2 Pneumococcal Vaccine Market Restraints
    12.3 Pneumococcal Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Pneumococcal Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Pneumococcal Vaccine
    13.3 Pneumococcal Vaccine Production Process
    13.4 Pneumococcal Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Pneumococcal Vaccine Typical Distributors
    14.3 Pneumococcal Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
    Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 4. Pfizer Major Business
    Table 5. Pfizer Pneumococcal Vaccine Product and Services
    Table 6. Pfizer Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Pfizer Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Pneumococcal Vaccine Product and Services
    Table 11. GSK Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GSK Recent Developments/Updates
    Table 13. MSD Basic Information, Manufacturing Base and Competitors
    Table 14. MSD Major Business
    Table 15. MSD Pneumococcal Vaccine Product and Services
    Table 16. MSD Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. MSD Recent Developments/Updates
    Table 18. Sanofipasteur Basic Information, Manufacturing Base and Competitors
    Table 19. Sanofipasteur Major Business
    Table 20. Sanofipasteur Pneumococcal Vaccine Product and Services
    Table 21. Sanofipasteur Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Sanofipasteur Recent Developments/Updates
    Table 23. CDIBP Basic Information, Manufacturing Base and Competitors
    Table 24. CDIBP Major Business
    Table 25. CDIBP Pneumococcal Vaccine Product and Services
    Table 26. CDIBP Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. CDIBP Recent Developments/Updates
    Table 28. Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
    Table 29. Global Pneumococcal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 30. Global Pneumococcal Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
    Table 31. Market Position of Manufacturers in Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 32. Head Office and Pneumococcal Vaccine Production Site of Key Manufacturer
    Table 33. Pneumococcal Vaccine Market: Company Product Type Footprint
    Table 34. Pneumococcal Vaccine Market: Company Product Application Footprint
    Table 35. Pneumococcal Vaccine New Market Entrants and Barriers to Market Entry
    Table 36. Pneumococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 37. Global Pneumococcal Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
    Table 38. Global Pneumococcal Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
    Table 39. Global Pneumococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 40. Global Pneumococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 41. Global Pneumococcal Vaccine Average Price by Region (2018-2023) & (USD/Dose)
    Table 42. Global Pneumococcal Vaccine Average Price by Region (2024-2029) & (USD/Dose)
    Table 43. Global Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 44. Global Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 45. Global Pneumococcal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 46. Global Pneumococcal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 47. Global Pneumococcal Vaccine Average Price by Type (2018-2023) & (USD/Dose)
    Table 48. Global Pneumococcal Vaccine Average Price by Type (2024-2029) & (USD/Dose)
    Table 49. Global Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 50. Global Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 51. Global Pneumococcal Vaccine Consumption Value by End User (2018-2023) & (USD Million)
    Table 52. Global Pneumococcal Vaccine Consumption Value by End User (2024-2029) & (USD Million)
    Table 53. Global Pneumococcal Vaccine Average Price by End User (2018-2023) & (USD/Dose)
    Table 54. Global Pneumococcal Vaccine Average Price by End User (2024-2029) & (USD/Dose)
    Table 55. North America Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 56. North America Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 57. North America Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 58. North America Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 59. North America Pneumococcal Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
    Table 60. North America Pneumococcal Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
    Table 61. North America Pneumococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 62. North America Pneumococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 63. Europe Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 64. Europe Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 65. Europe Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 66. Europe Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 67. Europe Pneumococcal Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
    Table 68. Europe Pneumococcal Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
    Table 69. Europe Pneumococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 70. Europe Pneumococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 71. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 72. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 73. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 74. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 75. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
    Table 76. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
    Table 77. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 78. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 79. South America Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 80. South America Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 81. South America Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 82. South America Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 83. South America Pneumococcal Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
    Table 84. South America Pneumococcal Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
    Table 85. South America Pneumococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 86. South America Pneumococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 87. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
    Table 88. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
    Table 89. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2018-2023) & (K Doses)
    Table 90. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2024-2029) & (K Doses)
    Table 91. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
    Table 92. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
    Table 93. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 95. Pneumococcal Vaccine Raw Material
    Table 96. Key Manufacturers of Pneumococcal Vaccine Raw Materials
    Table 97. Pneumococcal Vaccine Typical Distributors
    Table 98. Pneumococcal Vaccine Typical Customers
List of Figures
    Figure 1. Pneumococcal Vaccine Picture
    Figure 2. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Pneumococcal Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. PPSV 23 Examples
    Figure 5. PCV 7/13 Examples
    Figure 6. PCV 10 Examples
    Figure 7. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Pneumococcal Vaccine Consumption Value Market Share by End User in 2022
    Figure 9. Child Examples
    Figure 10. Adult Examples
    Figure 11. Global Pneumococcal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Pneumococcal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Pneumococcal Vaccine Sales Quantity (2018-2029) & (K Doses)
    Figure 14. Global Pneumococcal Vaccine Average Price (2018-2029) & (USD/Dose)
    Figure 15. Global Pneumococcal Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Pneumococcal Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Pneumococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Pneumococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Pneumococcal Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Pneumococcal Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Pneumococcal Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Pneumococcal Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Pneumococcal Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Pneumococcal Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Pneumococcal Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Pneumococcal Vaccine Average Price by Type (2018-2029) & (USD/Dose)
    Figure 30. Global Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 31. Global Pneumococcal Vaccine Consumption Value Market Share by End User (2018-2029)
    Figure 32. Global Pneumococcal Vaccine Average Price by End User (2018-2029) & (USD/Dose)
    Figure 33. North America Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 35. North America Pneumococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Pneumococcal Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 42. Europe Pneumococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Pneumococcal Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 51. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Pneumococcal Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 61. South America Pneumococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Pneumococcal Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by End User (2018-2029)
    Figure 67. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Pneumococcal Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Pneumococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Pneumococcal Vaccine Market Drivers
    Figure 74. Pneumococcal Vaccine Market Restraints
    Figure 75. Pneumococcal Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of Pneumococcal Vaccine
    Figure 79. Pneumococcal Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source